N-((3R,4S)-4-(6-(3,5-dimethoxy-2,6-dimethylphenyl)-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-ylamino)tetrahydrofuran-3-yl)acrylamide

ID: ALA4788621

PubChem CID: 90436766

Max Phase: Preclinical

Molecular Formula: C25H29N5O5

Molecular Weight: 479.54

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(C)c(OC)cc(OC)c3C)c(=O)n(C)c2n1

Standard InChI:  InChI=1S/C25H29N5O5/c1-7-21(31)27-17-11-35-12-18(17)28-25-26-10-15-8-16(24(32)30(4)23(15)29-25)22-13(2)19(33-5)9-20(34-6)14(22)3/h7-10,17-18H,1,11-12H2,2-6H3,(H,27,31)(H,26,28,29)/t17-,18+/m0/s1

Standard InChI Key:  XMTUBCFDOXDZIL-ZWKOTPCHSA-N

Molfile:  

 
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   25.4347  -19.4722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4335  -20.2959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1457  -20.7090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8595  -20.2954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8567  -19.4686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1439  -19.0634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7249  -20.7058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0177  -20.2903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0141  -21.9320    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.7304  -21.5258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3028  -21.5207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3114  -20.7018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6071  -20.2847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8937  -20.6894    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.8890  -21.5114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5940  -21.9207    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.1415  -18.2421    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.8521  -17.8272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5720  -20.7070    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.5733  -21.5283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4373  -21.9357    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.0107  -22.7533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1750  -21.9162    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.4654  -21.5038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3832  -20.6850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5806  -20.5067    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.1682  -21.2163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7118  -21.8306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5367  -22.6329    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7538  -22.8804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5787  -23.6828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7958  -23.9344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1459  -22.3297    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.7274  -19.0629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1455  -21.5262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  7 10  1  0
  8 12  1  0
 11  9  1  0
  9 10  1  0
  2  7  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  6 17  1  0
 17 18  1  0
  4 19  1  0
 19 20  1  0
 10 21  2  0
  9 22  1  0
 15 23  1  0
 24 23  1  1
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 24  1  0
 28 29  1  1
 29 30  1  0
 30 31  1  0
 31 32  2  0
 30 33  2  0
  1 34  1  0
  3 35  1  0
M  END

Associated Targets(Human)

FGFR2 Tclin Fibroblast growth factor receptor 2 (3405 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR4 Tclin Fibroblast growth factor receptor 4 (3668 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 479.54Molecular Weight (Monoisotopic): 479.2169AlogP: 2.11#Rotatable Bonds: 7
Polar Surface Area: 116.60Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.52CX Basic pKa: 3.64CX LogP: 2.34CX LogD: 2.34
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.50Np Likeness Score: -0.11

References

1. Liu H,Niu D,Tham Sjin RT,Dubrovskiy A,Zhu Z,McDonald JJ,Fahnoe K,Wang Z,Munson M,Scholte A,Barrague M,Fitzgerald M,Liu J,Kothe M,Sun F,Murtie J,Ge J,Rocnik J,Harvey D,Ospina B,Perron K,Zheng G,Shehu E,D'Agostino LA.  (2020)  Discovery of Selective, Covalent FGFR4 Inhibitors with Antitumor Activity in Models of Hepatocellular Carcinoma.,  11  (10): [PMID:33062171] [10.1021/acsmedchemlett.9b00601]

Source